Skip to content
SPACListing
Browse
ScreenerFilingsMarketDeadlinesSponsorsBanksSectorsLearnPricingWatchlist
Liquidated

Future Health ESG Corp.

CIK 0001851182

Cash in trust

$17.1M

$17,101,935

Trust per share

$10.14

Redemption value

IPO

Sep 2021

$201.0M raised

Combination deadline

Not disclosed

Filings on record

121

Latest Aug 8, 2025

Overview

Future Health ESG Corp. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001851182. It completed its initial public offering in Sep 2021, raising $201.0M in gross proceeds. The vehicle is sponsored by Future Health ESG. Deadline lapsed without a deal; trust returned to public shareholders.

Reading the filings

Arithmetic on what Future Health ESG Corp. has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.

  • Trust versus the $10 unit

    The trust holds $10.14 per public share, 1.4% above the $10.00 the units were sold at. That spread is accrued interest on the trust and, where the charter provides for it, sponsor contributions paid in to buy more time. It is the floor a public shareholder can redeem at, not a valuation of the business.

SEC filing history

Free tier: filings older than 24 hours
  • 25-NSE

    Notification of delisting

    Accession 0001354457-25-000793

    Aug 8, 2025

    1y ago

    Open filing
  • SCHEDULE 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001326389-25-000144

    Mar 7, 2025

    1y ago

    Open filing
  • 4

    Statement of changes in beneficial ownership

    Accession 0001326389-25-000101

    Feb 14, 2025

    1y ago

    Open filing
  • SC 13G/A

    Amended beneficial ownership report (passive)

    Accession 0001326389-24-000172

    Nov 14, 2024

    1y ago

    Open filing
  • 8-K

    Current report

    Item 5.02 · Accession 0001104659-24-099846

    Sep 13, 2024

    2y ago

    Open filing
  • NT 10-Q

    Late quarterly report notification

    Accession 0001104659-24-090255

    Aug 16, 2024

    2y ago

    Open filing
  • 8-K

    Current report

    Item 5.02 · Accession 0001104659-24-068683

    Jun 5, 2024

    2y ago

    Open filing
  • NT 10-Q/A

    NT 10-Q/A

    Accession 0001104659-24-063874

    May 21, 2024

    2y ago

    Open filing
  • 8-K

    Notice of delisting or failure to satisfy a listing rule

    Item 3.01 · Accession 0001104659-24-063865

    May 21, 2024

    2y ago

    Open filing
  • 4

    Statement of changes in beneficial ownership

    Accession 0001326389-24-000126

    May 16, 2024

    2y ago

    Open filing
  • NT 10-Q

    Late quarterly report notification

    Accession 0001104659-24-061162

    May 14, 2024

    2y ago

    Open filing
  • SC 13D

    Beneficial ownership report (activist)

    Accession 0001104659-24-050662

    Apr 23, 2024

    2y ago

    Open filing
  • 4

    Statement of changes in beneficial ownership

    Accession 0001104659-24-048025

    Apr 17, 2024

    2y ago

    Open filing
  • 4

    Statement of changes in beneficial ownership

    Accession 0001104659-24-048024

    Apr 17, 2024

    2y ago

    Open filing
  • 4

    Statement of changes in beneficial ownership

    Accession 0001104659-24-048023

    Apr 17, 2024

    2y ago

    Open filing
  • SC 13G/A

    SC 13G/A

    Accession 0001104659-24-048022

    Apr 17, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000142

    Apr 8, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000141

    Apr 8, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000140

    Apr 8, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000139

    Apr 8, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000138

    Apr 8, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001474506-24-000137

    Apr 5, 2024

    2y ago

    Open filing
  • 8-K

    Termination of a material definitive agreement; Other events

    Items 1.02, 5.02, 8.01, 9.01 · Accession 0001104659-24-039704

    Mar 27, 2024

    2y ago

    Open filing
  • 10-K

    Annual report

    Accession 0001410578-24-000237

    Mar 19, 2024

    2y ago

    Open filing
  • 8-K

    Entry into a material definitive agreement

    Items 1.01, 9.01 · Accession 0001104659-24-031549

    Mar 6, 2024

    2y ago

    Open filing
  • SC 14F1

    SC 14F1

    Accession 0001104659-24-031094

    Mar 5, 2024

    2y ago

    Open filing
  • 8-K

    Entry into a material definitive agreement

    Items 1.01, 5.02, 9.01 · Accession 0001104659-24-026639

    Feb 22, 2024

    2y ago

    Open filing
  • 8-K

    Entry into a material definitive agreement

    Items 1.01, 2.03, 9.01 · Accession 0001104659-24-007840

    Jan 29, 2024

    2y ago

    Open filing
  • 3

    Initial statement of beneficial ownership

    Accession 0001326389-24-000002

    Jan 12, 2024

    2y ago

    Open filing
  • 8-K

    Entry into a material definitive agreement; Submission of matters to a vote of security holders

    Items 1.01, 5.03, 5.07, 9.01 · Accession 0001104659-24-001447

    Jan 4, 2024

    2y ago

    Open filing

Future Health ESG Corp.: questions answered

What is Future Health ESG Corp.?

Future Health ESG Corp. is a special purpose acquisition company incorporated in Delaware and registered with the SEC under CIK 0001851182. It completed its initial public offering in Sep 2021, raising $201.0M in gross proceeds. The vehicle is sponsored by Future Health ESG. Deadline lapsed without a deal; trust returned to public shareholders.

How much does Future Health ESG Corp. hold in trust?

Approximately $17,101,935, or about $10.14 per public share, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.

When must Future Health ESG Corp. complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if Future Health ESG Corp. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in Future Health ESG Corp., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date, most recently disclosed at about $10.14 per share. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

Is the trust value the same as the share price for Future Health ESG Corp.?

No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.

Who sponsors Future Health ESG Corp., and what is their track record?

Future Health ESG is the sponsor entity, part of the Future Health ESG franchise. This is the only vehicle we have attributed to that sponsor.

Is Future Health ESG Corp. a good investment?

That is not a question this site answers. Future Health ESG Corp. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this Future Health ESG Corp. data come from?

Filings Future Health ESG Corp. submitted to the SEC under CIK 0001851182: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Sep 4, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.